Nuwellis announces closing of $2.7 million public offering

Minneapolis, april 30, 2024 (globe newswire) -- nuwellis, inc. (nasdaq: nuwe) (“nuwellis” or the “company”), a medical technology company focused on transforming the lives of people with fluid overload, today announced the closing of its previously announced public offering of 11,250,000 shares of its common stock (or pre-funded warrants in lieu thereof) and warrants to purchase up to an aggregate of 16,875,000 shares of its common stock at a combined public offering price of $0.24 per share (or pre-funded warrant in lieu thereof) and associated warrant. each share of common stock (or prefunded warrant in lieu thereof) was sold together with one warrant to purchase one and a half shares of common stock. the warrants have an exercise price of $0.40 per share, are exercisable immediately upon issuance, and will expire five years following the date of issuance.
NUWE Ratings Summary
NUWE Quant Ranking